Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib

Afatinib is an oral tyrosine kinase inhibitor (TKI) approved for treating advanced non-small cell lung cancer. It is necessary to develop a simple quantification method for TKIs in order to facilitate therapeutic drug monitoring (TDM) in clinical settings. This study sought to develop a simple and s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rintaro Sogawa (Autor), Tetsuya Saita (Autor), Yuta Yamamoto (Autor), Sakiko Kimura (Autor), Yutaka Narisawa (Autor), Shinya Kimura (Autor), Masashi Shin (Autor)
Format: Llibre
Publicat: Elsevier, 2019-02-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible